Tech4Eva Roadshow - The Connection to France

Steve Chick is a Professor of Technology and Operations Management at INSEAD. He was named Academic Director of INSEAD's Healthcare Management Initiative and Novartis Chair of Healthcare Management in 2008. He earned his MS and PhD from the University of California at Berkeley in Industrial Engineering and Operations Research and his BS in Mathematics from Stanford University. Prior to joining INSEAD, he taught process modelling, simulation, and information systems as a faculty member at the University of Michigan and had worked for five years in the automotive and software industries. In the MBA program at INSEAD, he teaches the ‘Creating Value in Health’ and ‘Identifying New Business Models’ electives and has taught the Process and Operations Management core course and the Management of Services elective. He also teaches in the PhD programme. In executive education, he teaching operations strategy, improvement and innovation, and was academic director of three programs in Executive Education, the Middle East Health Leadership Programme (MEHLP), Innovating Health for Tomorrow (IHT), and Strategic Innovation for Community Health (STICH). He also designs and delivers customized executive development programs in business model innovation for health care delivery and pharmaceutical organizations.

With over 20 years of experience in the cancer drug development industry, I am the CEO of OncoGenomX, a prediction software company that revolutionizes individualized drug-tumor matching. Our software, PredictionStar, enables prescription of more than 20 different anti-cancer drugs based on the patient's tumor profile, for certainty of therapy success before starting treatment.

As the pioneers of biology-based drug-tumor matching and the leader of reliable outcome prediction, OncoGenomX is already a trusted name among breast cancer specialists. I work closely with oncologists, clinical researchers, international clinical study groups, and business development partners to advance our mission of ending under- and overtreatment of patients, avoiding unnecessary costs, and minimizing the risk of therapy failure and liability. I am also an entrepreneur and a strategic consultant with a MD focused on Oncology, Tumor Biology, and Cancer Genetics from the University of Innsbruck. I have multiple honors and certifications in my field, including being named one of 'Europe's Top 5 Effective Leaders in Healthcare', 'Most Innovative CEO in the FemTech Industry', and 'Healthcare CEO of the Year Switzerland'.

‍

Simone has 25+ years of event management, strategy, marketing, relationship building experience. She joined the EPFL Innovation Park team in 2020 and she currently manages the Tech4Eva accelerator operations, events and community marketing and the Tech4Growth initiative.

For 16 years she built the brand/network of Tech Tour as their Managing Director leading the events team to implement 25+ tech events per year. She has a proven ability to set up well-oiled processes and leverage networks to open partnership opportunities to build a strong ecosystem by maximizing objectives and engaging all stakeholders (corporates, investors, academia, tech start-ups in all digital sectors).

Previously she worked for the University of NC in Chapel Hill, USA, implementing the new graduate student program. She also worked at SCIP as their global operations & marketing manager both in Alexandria, VA & in London, UK, where she opened and managed their branch office to establish their European presence, as well as overseeing all aspects of international conferences & tradeshows.

She holds a Bachelor of Science in Economics from the University of North Carolina at Greensboro, NC, USA. She is fluent in English, French & German.